Head of Market Access Germany

Together into the Future...

To strengthen our German Commercial Team, we are currently recruiting for a

**Head of Market Access Germany**:
to be located in Hattersheim (Frankfurt area).
- The incumbent is the responsible functional team leader for all domains of market access in Germany,
- therefore the position holder will be responsible for achieving access and maintaining optimal pricing, reimbursement, HTA positioning, stakeholder engagement and ultimately access to appropriate patients for CSL Behring’s portfolio of products across the country.
- Due to the broad portfolio of CSL Behring - from blood plasma products, to recombinant protein therapies and finally gene therapies in diverse indications - the market access lead is responsible for ensuring and improving the market access of our innovative products as well as established drugs in an ongoingly changing political and market access -environment.
- In this context the mid and long-term planning is essential and the market access lead plays a vital role in driving the external agenda in close collaboration with the European governmental affairs organization.
- Due to an extensive pipeline in research and development the incumbent is heavily involved in early medicine development processes to guide and consult regional and global functions in the specific needs of the German market and especially the payer environment.
- To ensure an appropriate collaboration the incumbent is member of the German Leadership Team and European Market Access Lead Team.

**Main Responsibilities and Accountabilities**:

- Build, lead and develop Market Access team and function within German affiliate and the organizational matrix environment
- Development and implementation of market access and reimbursement strategies for the the entire product life cycle from the market access perspective for CSL Behring products across Germany in line with global and regional strategies in order to meet agreed pricing, reimbursement, HTA positioning and patient access targets. Execution of innovative Patient access and Patient management projects.
- Monitoring of the legal health policy environment and the competitive situation, anticipation of potential prescription and reimbursement hurdles for the product portfolio and development of specific solutions
- Lead the negotiation team, being responsible for the preparation and negotiation of the central reimbursement negotiations with the GKV-Spitzenverband (130b SGB V) in collaboration with the relevant departments. This includes the continuous analysis of past and ongoing AMNOG proceedings including arbitration decisions to identify relevant pricing and negotiation strategies for the CSL Behring product portfolio.
- Build valuable relationships with payers, local patient groups, other associations and relevant market access and reimbursement stakeholders, that will be utilized to impact payment and access decisions. Convey knowledge of CSL Behring and its issues within these offices and negotiate solutions and successful outcomes. Represent CSL Behring at key Institutional, trade and Specialty Pharmacy Association meetings. Develop and maintain contacts with opinion leaders, customers, patient groups, local Industry associations etc. Communicate facts and opinions with clarity and transparency.
- Timely, complete and accurate preparation, submission and management of all materials and negotiations with German market access external stakeholder organizations e.g. GBA, health insurances (Krankenkassen), their associations, etc.. Coordinate cooperation with external vendors.
- Collaborate with regional access colleagues as necessary in the development and execution of pricing, reimbursement, HTA and other market access plans by providing the local market perspective, always taking into account the broader regional implications as well.
- Horizon scanning and monitoring of health policy environment and chages to align our data generation and dissemination.

**Position Qualifications and Experience**:

- University degree in a related field. Graduate degree in business or economics Epidemiology, Health Economics, or Public Health desirable.
- 5 years of relevant industry work experience in reimbursement/market access management in pharmaceutical industry, with rare disease/speciality indications preferred, is required.
- An understanding of and/or experience with the German reimbursement environment is required - further expertise in the payer environment of other countries of the cluster organisation are welcomed. Knowledge of healthcare systems and policy issues, pharma/plasma industry commercial business model and how it relates to policy and key stakeholders, knowledge of economic principles of pricing and pharmaceutical markets. A thorough understanding of pharmaceutical commercialization and drug development process is also required.
- Experience with developing and submission of Reimbursement & Pricing dossiers to key governmen